Covered recipient · General Payments record
RICHARD C SEESTEDT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,272.93
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $582.47 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $232.00 | 2 |
| Lilly USA, LLC | $160.04 | 3 |
| Acerta Pharma LLC | $94.68 | 1 |
| ABBVIE INC. | $33.29 | 1 |
| PFIZER INC. | $29.98 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.50 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.29 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106051490 | CMS |
| AstraZeneca Pharmaceuticals LP | $94.68 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105667797 | CMS |
| Lilly USA, LLC | $15.87 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135334330 | CMS |
| Lilly USA, LLC | $25.37 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135357221 | CMS |
| Lilly USA, LLC | $118.80 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135353666 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.98 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118978376 | CMS |
| PFIZER INC. | $29.98 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131184113 | CMS |
| Teva Pharmaceuticals USA, Inc. | $118.60 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151701526 | CMS |
| Teva Pharmaceuticals USA, Inc. | $113.40 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151701592 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.50 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105910904 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.